From Bioblast
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
FR Bordeaux Rossignol R
O2k-Network Lab | INSERM-EMI 9929
Université Victor Segalen |
---|---|
Address | 146, rue Léo Saignat, 33076 |
City | Bordeaux |
State/Prov | |
Country | France |
Weblink | |
Contact | Rossignol Rodrigue, Amoedo Nivea D |
Team | Bellance Nadege, Gutierrez Cortes Nicolas, Mazat Jean-Pierre, Saharnaz Sarlak |
Team previous | Jose Caroline |
Status | 2 Power-O2k 2003- |
Oroboros Events | IOC137, MiP2015, MiP2014, MiP2013, Bioblast 2012, IOC72, IOC54, IOC39, IOC23, IOC13 |
Topics |
O2k-Publications
Published | Reference | |
---|---|---|
Amoedo 2021 J Clin Invest | 2021 | Amoedo ND, Sarlak S, Obre E, Esteves P, Bégueret H, Kieffer Y, Rousseau B, Dupis A, Izotte J, Bellance N, Dard L, Redonnet-Vernhet I, Punzi G, Rodrigues MF, Dumon E, Mafhouf W, Guyonnet-Dupérat V, Gales L, Palama T, Bellvert F, Dugot-Senan N, Claverol S, Baste JM, Lacombe D, Rezvani HR, Pierri CL, Mechta-Grigoriou F, Thumerel M, Rossignol R (2021) Targeting the mitochondrial trifunctional protein restrains tumor growth in oxidative lung carcinomas. J Clin Invest 131:e133081. |
Bastos Sant'Anna Silva 2021 Cancers (Basel) | 2021 | Bastos Sant'Anna Silva AC, Perez Valencia JA, Sciacovelli M, Lalou C, Sarlak S, Tronci L, Nikitopoulou E, Meszaros AT, Frezza C, Rossignol R, Gnaiger E, Klocker H (2021) Succinate anaplerosis has an onco-driving potential in prostate cancer cells. https://doi.org/10.3390/cancers13071727 |
Esteves 2019 Oncogene | 2019 | Esteves P, Dard L, Brillac A, Hubert C, Sarlak S, Rousseau B, Dumon E, Izotte J, Bonneu M, Lacombe D, Dupuy JW, Amoedo N, Rossignol R (2019) Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F. Oncogene 39:617-36. |
Szelechowski 2018 Sci Rep | 2018 | Szelechowski M, Amoedo N, Obre E, Léger C, Allard L, Bonneu M, Claverol S, Lacombe D, Oliet S, Chevallier S, Le Masson G, Rossignol R (2018) Metabolic reprogramming in amyotrophic lateral sclerosis. Sci Rep 8:3953. |
Jose 2018 Redox Biol | 2018 | Jose C, Hebert-Chatelain E, Dias Amoedo N, Roche E, Obre E, Lacombe D, Rezvani HR, Pourquier P, Nouette-Gaulain K, Rossignol R (2018) Redox mechanism of levobupivacaine cytostatic effect on human prostate cancer cells. Redox Biol 18:33-42. |
Rodrigues 2016 Biochem J | 2015 | Rodrigues MF, Obre E, Melo FH, Santos-Jr GC, Galina A, Jasiulionis MG, Rossignol R, Rumjanek FD, Amoedo ND (2016) Enhanced OXPHOS, glutaminolysis and beta-oxidation constitute the metastatic phenotype of melanoma cells. https://doi.org/10.1042/BJ20150645 |
Jose 2012 Thesis | 2012 | Jose C (2012) Rôle des mitochondries dans la tumorigénèse: implications pour le traitement du cancer. PhD Thesis 272. |
Smolkova 2010 J Bioenerg Biomembr | 2010 | Smolková K, Bellance N, Scandurra F, Génot E, Gnaiger E, Plecitá-Hlavatá L, Ježek P, Rossignol R (2010) Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia. https://doi.org/10.1007/s10863-009-9267-x |
Bellance 2009 Int J Biochem Cell Biol | 2009 | Bellance N, Benard G, Furt F, Begueret H, Smolková K, Passerieux E, Delage JP, Baste JM, Moreau P, Rossignol R (2009) Bioenergetics of lung tumors: Alteration of mitochondrial biogenesis and respiratory capacity. Int J Biochem Cell Biol 41:2566-77. |
O2k-Abstracts
Published | Reference | |
---|---|---|
Amoedo 2015 Abstract MiP2015 | 2015 | The energy requirement of metastatic cells. |
Rodrigues 2014 Abstract MiP2014 | 2014 | Bioenergetics’ traits of tongue cancer metastatic cells. |